dc.contributorMassachusetts Gen Hosp
dc.contributorBrigham & Womens Hosp
dc.contributorHarvard Med Sch
dc.contributorUniversidade de São Paulo (USP)
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorNew England Trophoblast Dis Ctr
dc.contributorDana Farber Canc Inst
dc.contributorHarvard Univ
dc.date.accessioned2021-06-25T11:24:00Z
dc.date.accessioned2022-12-19T22:46:20Z
dc.date.available2021-06-25T11:24:00Z
dc.date.available2022-12-19T22:46:20Z
dc.date.created2021-06-25T11:24:00Z
dc.date.issued2019-06-01
dc.identifierGynecologic Oncology. San Diego: Academic Press Inc Elsevier Science, v. 154, p. 37-38, 2019.
dc.identifier0090-8258
dc.identifierhttp://hdl.handle.net/11449/208892
dc.identifier10.1016/j.ygyno.2019.04.089
dc.identifierWOS:000581778900075
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5389489
dc.languageeng
dc.publisherElsevier B.V.
dc.relationGynecologic Oncology
dc.sourceWeb of Science
dc.titleEpigenetics tells themole story: DNA methylation identifies complete moles destined to develop into gestational trophoblastic neoplasia
dc.typeOtros


Este ítem pertenece a la siguiente institución